Our Therapies

The first and only FDA-approved
treatment for Demodex blepharitis

SEC Filing Details

Document Details

Form
Filing Date
October 11, 2022
Document Date
October 6, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Tarsus Pharmaceuticals
Issuer
TARSUS PHARMACEUTICALS, INC.